Company now has nine such facilities in major global regions.
Firms will work together to develop pandemic H5N1 vaccine for manufacture in Japan.
Beads are designed to extract antibodies from cell cultures and sera.
Collaboration will use SistemQC platform to help ensure standardization of cells for clinical applications.
Cerus has put in place separate agreements that will see the American Red Cross, and Blood Systems manufacture its Intercept plasma for use in the transfusion of thrombotic thrombocytopenic purpura (TTP) patients, once the product has been approved by FDA.
Laboratory acquired two Biotage peptide synthesizers and will provide training facilities.
Udit Batra, Ph.D., told GEN, his company is working to shorten the supply chain and unclog other bottlenecks to CAR-T development besides vector supply.
Acquisition will significantly expand buyer's capabilities by adding research and development, formulation, lab analysis and commercial and clinical manufacturing
Acquisition will double Repligen’s manufacturing capacity and add native Protein A product to portfolio.
Testa Center focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences, aligning with Sweden's goals of strengthening its capacity for innovation and thus its economic competitiveness.